UK Precision Peptides

Retatrutide 15mg

Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and Glucagon receptors simultaneously. This unique multi-receptor action makes it one of the most potent tools in metabolic research, supporting significant fat loss, appetite control, and metabolic balance. The 15mg format is intended for advanced metabolic research protocols requiring higher dosing.

Dose: 4–6 mg per injection
Administration: SubQ (Subcutaneous) injection
Frequency: Once weekly
Best Time: Anytime of day

Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and Glucagon receptors simultaneously. This unique multi-receptor action makes it one of the most potent tools in metabolic research, supporting significant fat loss, appetite control, and metabolic balance. The 15mg format is intended for advanced metabolic research protocols requiring higher dosing.

Performance
Rating
Weight Loss
Appetite Suppression
Metabolic Health
Body Composition
Energy & Vitality
Cardiovascular Health
Safety & Tolerance
Overall Wellness

Benefits

Significant & sustained weight loss
Powerfully suppresses appetite & cravings
Improves blood sugar control & insulin sensitivity
Enhances fat metabolism & energy expenditure
Supports healthy body composition
Helps reduce visceral fat
Supports cardiovascular & metabolic health
Promotes overall wellness & vitality

Contact form

This field is required